Maira Dastgir N on Microvascular Dysfunction in Geriatrics
Maira Dastgir N, Global Chief of Transitional Care for Global Population Healthcare Management Forum, shared on LinkedIn:
”In geriatric care, we often focus on macro events like heart attacks or strokes.
However, the root of many geriatric syndromes like dementia, depression, and frailty often lies at the microvascular level.
I reviewed an interesting article recently that caught my attention, The Maastricht Study findings on alcohol and Microvascular Dysfunction (MVD).
The researchers found a J-shaped association which meant light-to-moderate consumption was linked to lower MVD compared to abstinence, while high consumption worsened it.
As primary care doctors, we are dedicated to prevention and often view alcohol through a binary lens of “healthy” vs. “unhealthy.”
But for our aging population, the microvasculature is the frontline of defense against cognitive decline and physical frailty. This study suggests that:
1) Dietary interventions are not one-size-fits-all. The way a patient’s body handles alcohol and its impact on small vessels depends heavily on their metabolic profile.
2) The “Micro” is the Key to the “Macro”. By the time a patient presents with geriatric syndromes like depression or dementia, microvascular damage may already be advanced. We must broaden our horizons to include early microvascular screening as a preventive standard.
3) While we cannot and should not recommend increasing alcohol intake as a broad policy, we must understand these biological nuances to provide truly personalized geriatric care.
Shifting our focus from large-vessel events to early microvascular screening and dietary nuances can help diagnose minor dysfunction before it becomes a major clinical disease.
I have linked the article here.”
Article: Alcohol consumption and microvascular dysfunction: a J-shaped association: The Maastricht Study
Authors: Frank C. T. van der Heide, Simone J. P. M. Eussen, Alfons J. H. M. Houben, Ronald M. A. Henry, Abraham A. Kroon, Carla J. H. van der Kallen, Pieter C. Dagnelie, Martien C. J. M. van Dongen, Tos T. J. M. Berendschot, Jan S. A. G. Schouten, Carroll A. B. Webers, Marleen M. J. van Greevenbroek, Anke Wesselius, Casper G. Schalkwijk, Annemarie Koster, Jacobus F. A. Jansen, Walter H. Backes, Joline W. J. Beulens, Coen D. A. Stehouwer

Stay updated on all scientific advances with Hemostasis Today.
-
Jan 16, 2026, 04:11Open-Label Extension Study of Marstacimab: Pfizer Has Reported a Fatal Event
-
Jan 16, 2026, 04:11Why is DVT More Common In the Left Leg? Dr Raheel Moazzam’s New Study Gives Answers!
-
Jan 15, 2026, 21:00Sebastian Szmit To Deliver a Speech at 13th ICTHIC
-
Jan 15, 2026, 19:09Angelique Balguid and Atul Gupta on How Dr Paul Bhogal and Barts Health NHS Trust Improve Stroke Care
-
Jan 15, 2026, 17:20Michel Mawad: Prevention Starts With Simple Daily Habits
-
Jan 15, 2026, 15:09Louise St Germain Bannon: ISTH Education is Off to An Exciting Start in 2026
-
Jan 15, 2026, 13:12Michele Romoli: What is The Optimal Treatment Strategy After Stroke While on DOAC?
-
Jan 15, 2026, 12:18Isabelle Mahé on Reduced Dose Apixaban and Cancer-Associated VTE
-
Jan 15, 2026, 04:52Lucien Blondel on Resolve Stroke: To Be Used In the SCULPT Trial
